,Unnamed: 0,Dates,Headlines,Links,Last0,TradeTime0,Last20,TradeTime20,Last60,TradeTime60,Last120,TradeTime120
0,0,2017-02-28 20:55:13,Target pledges to reinvest in business after weak quarter,http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/target-misses-street-4q-forecasts-113729782.html,122.33,2017-02-28 20:55:00,122.23,2017-02-28 21:00:00,122.23,2017-02-28 21:00:00,122.23,2017-02-28 21:00:00
1,1,2017-02-28 20:55:13,Target pledges to reinvest in business after weak quarter,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/target-misses-street-4q-forecasts-113729530.html,122.33,2017-02-28 20:55:00,122.23,2017-02-28 21:00:00,122.23,2017-02-28 21:00:00,122.23,2017-02-28 21:00:00
2,2,2017-02-28 17:06:12,What Drove Nordstrom?s Earnings in Fiscal 4Q16?,http://us.rd.yahoo.com/finance/external/marketrealist/rss/SIG=129t1c0jo/*http://marketrealist.com/2017/02/drove-nordstroms-earnings-fiscal-4q16/?utm_source=yahoo&utm_medium=feed,122.31,2017-02-28 17:06:00,122.17,2017-02-28 17:26:00,122.29,2017-02-28 18:06:00,122.22,2017-02-28 19:07:00
3,3,2017-02-28 16:46:00,"A Memorable 2017, But Not in a Good Way; Why It Could Be Year of Retail Bankruptcies",http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1447jn2bo/*https://www.thestreet.com/story/14013732/1/a-memorable-2017-but-not-in-a-good-way-why-it-could-be-year-of-retail-bankruptcies.html?puc=yahoo&cm_ven=YAHOO,122.26,2017-02-28 16:46:00,122.31,2017-02-28 17:06:00,122.2,2017-02-28 17:46:00,122.3,2017-02-28 18:46:00
4,4,2017-02-28 16:41:48,Why Trump's budget math doesn't add up,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/why-trumps-budget-math-doesnt-add-up-164148167.html,122.25,2017-02-28 16:42:00,122.3,2017-02-28 17:02:00,122.2,2017-02-28 17:42:00,122.25,2017-02-28 18:42:00
5,5,2017-02-28 15:22:05,Johnson & Johnson -- Moody's rated J&J's notes Aaa; stable outlook,http://us.rd.yahoo.com/finance/external/xmoodys/rss/SIG=11h21r4n8/*http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_362645&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170228_PR_362645,122.36,2017-02-28 15:22:00,122.33,2017-02-28 15:43:00,122.31,2017-02-28 16:22:00,122.21,2017-02-28 17:22:00
6,6,2017-02-28 14:30:02,"Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly",http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/zacks-industry-outlook-highlights-johnson-143002844.html,122.06,2017-02-28 14:30:00,122.27,2017-02-28 14:50:00,122.44,2017-02-28 15:31:00,122.27,2017-02-28 16:30:00
7,0,2017-02-27 20:38:00,"Near an All-Time Low, Is J.C. Penney a Buy?",http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12n73tir0/*http://www.fool.com/investing/2017/02/27/near-an-all-time-low-is-jc-penney-a-buy.aspx,122.51,2017-02-27 20:38:00,122.39,2017-02-27 20:58:00,122.4,2017-02-27 21:00:00,122.4,2017-02-27 21:00:00
8,1,2017-02-27 20:23:00,[$$] Johnson & Johnson Prescription Unit List Prices Rose 8.5% Last Year,http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=13apunu7q/*https://www.wsj.com/articles/johnson-johnson-prescription-unit-list-prices-rose-8-5-last-year-1488226977?mod=yahoo_hs,122.4,2017-02-27 20:23:00,122.5,2017-02-27 20:43:00,122.4,2017-02-27 21:00:00,122.4,2017-02-27 21:00:00
9,2,2017-02-27 20:03:26,"Drugmakers pledge restraint, but prices will still soar",http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/drugmakers-pledge-restraint-prices-still-191004727.html,122.41,2017-02-27 20:03:00,122.4,2017-02-27 20:23:00,122.4,2017-02-27 21:00:00,122.4,2017-02-27 21:00:00
10,3,2017-02-27 20:03:26,"Drugmakers pledge restraint, but prices will still soar",http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/drugmakers-pledge-restraint-prices-still-191004283.html,122.41,2017-02-27 20:03:00,122.4,2017-02-27 20:23:00,122.4,2017-02-27 21:00:00,122.4,2017-02-27 21:00:00
11,4,2017-02-27 19:33:17,J&J says kept drug price increases below 10 percent since 2012,http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/j-j-says-kept-drug-193317673.html,122.26,2017-02-27 19:33:00,122.41,2017-02-27 19:53:00,122.47,2017-02-27 20:33:00,122.4,2017-02-27 21:00:00
12,5,2017-02-27 19:28:35,J&J says kept drug price increases below 10 pct since 2012,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/j-j-says-kept-drug-192835409.html,122.27,2017-02-27 19:28:00,122.4,2017-02-27 19:48:00,122.39,2017-02-27 20:29:00,122.4,2017-02-27 21:00:00
13,6,2017-02-27 19:24:00,J&J reveals 3.5% net hike in drug pricing last year,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/video/j-j-reveals-3-5-192400045.html,122.28,2017-02-27 19:24:00,122.36,2017-02-27 19:44:00,122.39,2017-02-27 20:24:00,122.4,2017-02-27 21:00:00
14,7,2017-02-27 18:23:00,Jim Cramer Is Passing on Valeant Ahead of Earnings,http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1347he82c/*https://www.thestreet.com/story/14017469/1/jim-cramer-is-passing-on-valeant-ahead-of-earnings.html?puc=yahoo&cm_ven=YAHOO,122.35,2017-02-27 18:23:00,122.34,2017-02-27 18:42:00,122.28,2017-02-27 19:23:00,122.4,2017-02-27 20:23:00
15,8,2017-02-27 18:00:00,Johnson & Johnson Transparency Report Shows 3.5% Increase in Drug Prices,http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13r5o8vq2/*https://www.thestreet.com/story/14017445/1/johnson-amp-johnson-transparency-report-shows-3-5-increase-in-drug-prices.html?puc=yahoo&cm_ven=YAHOO,122.36,2017-02-27 18:00:00,122.35,2017-02-27 18:20:00,122.33,2017-02-27 19:00:00,122.42,2017-02-27 20:00:00
16,9,2017-02-27 17:48:00,Johnson & Johnson reveals 3.5% net hike in drug pricing l...,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/video/johnson-johnson-reveals-3-5-174800715.html,122.36,2017-02-27 17:48:00,122.36,2017-02-27 18:07:00,122.36,2017-02-27 18:47:00,122.4,2017-02-27 19:48:00
17,10,2017-02-27 17:27:00,Walls Fargo analyst: Why we're optimistic on retail,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/video/walls-fargo-analyst-why-were-172700141.html,122.44,2017-02-27 17:27:00,122.38,2017-02-27 17:47:00,122.36,2017-02-27 18:27:00,122.28,2017-02-27 19:27:00
18,11,2017-02-27 16:00:40,"Johnson & Johnson lifts lid on drug pricing data, shows 3.5% net hike in 2016",http://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=112kjm8ek/*http://www.cnbc.com/id/104307141?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104307141,122.56,2017-02-27 16:01:00,122.59,2017-02-27 16:21:00,122.47,2017-02-27 17:01:00,122.36,2017-02-27 18:01:00
19,12,2017-02-27 15:05:00,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ortho-clinical-diagnostics-awarded-top-150500791.html,122.57,2017-02-27 15:05:00,122.6,2017-02-27 15:25:00,122.52,2017-02-27 16:05:00,122.36,2017-02-27 17:05:00
20,13,2017-02-27 14:54:05,[$$] VC Profile: OrbiMed Funds Novel Attacks on Cancer,http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12qgf48oe/*https://www.wsj.com/articles/vc-profile-orbimed-funds-novel-attacks-on-cancer-1488205956?mod=yahoo_hs,122.54,2017-02-27 14:54:00,122.49,2017-02-27 15:14:00,122.6,2017-02-27 15:54:00,122.52,2017-02-27 16:54:00
21,14,2017-02-27 14:50:20,"Better Buy: PDL BioPharma, Inc. vs. Johnson & Johnson",http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12vde8nev/*http://www.fool.com/investing/2017/02/27/better-buy-pdl-biopharma-inc-vs-johnson-johnson.aspx,122.48,2017-02-27 14:50:00,122.56,2017-02-27 15:11:00,122.63,2017-02-27 15:50:00,122.48,2017-02-27 16:50:00
22,15,2017-02-27 14:30:02,"The Zacks Analyst Blog Highlights: Wal-Mart Stores, Home Depot, E I Du Pont De Nemours, Dow Chemical and Johnson & Johnson",http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/zacks-analyst-blog-highlights-wal-143002897.html,122.34,2017-02-27 14:30:00,122.48,2017-02-27 14:50:00,122.63,2017-02-27 15:30:00,122.46,2017-02-27 16:30:00
